Kathryn Kosuda
Principal investigator, leads VAXESS TECHNOLOGIES INC.
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$4.3MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $4.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jan 30, 2021 | NIH | SBIR Phase II Improved Influenza Vaccine Efficacy Through Infection Mimicry | $1000K | VAXESS TECHNOLOGIES INC |
| Sep 1, 2020 | NSF | SBIR Phase I SBIR Phase I: At home, single dose mRNA vaccine patch (COVID-19) | $256K | VAXESS TECHNOLOGIES INC |
| Feb 21, 2020 | NIH | SBIR Phase II Improved Influenza Vaccine Efficacy Through Infection Mimicry | $998K | VAXESS TECHNOLOGIES INC |
| Apr 15, 2019 | NIH | SBIR Phase II Improved Influenza Vaccine Efficacy Through Infection Mimicry | $300K | VAXESS TECHNOLOGIES INC |
| Sep 20, 2016 | NSF | SBIR Phase II SBIR Phase II: A New Approach to Developing a Heat-stable Rotavirus Vaccine | $1.4M | VAXESS TECHNOLOGIES INC |
| Feb 12, 2015 | NIH | SBIR Phase I Development of a Silk-Stabilized Inactivated Polio Vaccine | $210K | VAXESS TECHNOLOGIES INC |
| 2015 | NSF | SBIR Phase I SBIR Phase I: Silk: A New Approach to Developing a Heat-stable Rotavirus Vaccine | $150K | VAXESS TECHNOLOGIES INC |
Peer ranks
Federal funding#378
Awards as PI#280
Patents#505
Companies
- VAXESS TECHNOLOGIES INCLeads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.